HER2+ biliary tract cancer

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

HER2+ biliary tract cancer

Nov 24, 2024, 18:03 | Blog

Elvina Almuradova: FDA approves Zanidatama for HER2+ biliary tract cancer

Elvina Almuradova, Associate Professor at Medicana Health Group, shared a post on X: "FDA approves…

All: 1 Posts: 1 - 100

Leukemia: Symptoms, Causes, Types, Diagnosis & Treatment

U.S. FDA Approval of Ziihera for the Previously Treated, Unresectable or IHC 3+ Biliary Tract Cancer

ASCO GI 2025 - Everything You Need To Know About Biggest Gastrointestinal cancer Symposium

Side Effects of Radiotherapy: Risks and What to Know

Isabel Rubio has been elected as the President of the European Cancer Organisation for 2026-2027

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023